Literature DB >> 14966306

Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically.

Joanne Layland1, David J Grieve, Alison C Cave, Emma Sparks, R John Solaro, Ajay M Shah.   

Abstract

PKA-dependent phosphorylation of cardiac troponin I (cTnI) contributes significantly to beta-adrenergic agonist-induced acceleration of myocardial relaxation (lusitropy). However, the role of PKA-dependent cTnI phosphorylation in the positive inotropic response to beta-adrenergic stimulation is unclear. We studied the contractile response to isoprenaline (10 nm) in isolated hearts and isolated cardiomyocytes from transgenic mice with cardiac-specific expression of slow skeletal TnI (ssTnI, which lacks the N-terminal protein extension containing PKA-sensitive phosphorylation sites in cTnI) and matched wild-type littermate controls. As expected, the lusitropic effect of isoprenaline was significantly blunted in ssTnI hearts. However, the positive inotropic response to isoprenaline was also blunted in ssTnI hearts. This effect was especially prominent for ejection-phase indices in isolated auxotonically loaded ssTnI hearts whereas the positive inotropic response of isovolumic hearts or unloaded isolated myocytes was much less affected. Isoprenaline decreased left ventricular end-systolic volume in wild-type hearts (10.6 +/- 1.6 to 6.2 +/- 0.4 microl at a preload of 20 cmH(2)O; P < 0.05) but not transgenic hearts (11.4 +/- 1.3 to 10.9 +/- 1.3 microl; P= n.s.). Likewise, isoprenaline increased stroke work in control hearts (14.5 +/- 1.0 to 22.5 +/- 1.8 mmHg microl mg(-1); P < 0.05) but not transgenic hearts (15.4 +/- 1.3 to 18.3 +/- 1.2 mmHg microl mg(-1); P= n.s.). The end-systolic pressure-volume relation was increased by isoprenaline to a greater extent in control than transgenic hearts. However, isoprenaline induced a similar rise in intracellular Ca(2+) transients in transgenic and non-transgenic cardiomyocytes. These results indicate that cTnI has a pivotal role in the positive inotropic response of the murine heart to beta-adrenergic stimulation, an effect that is highly dependent on loading conditions and is most evident in the auxotonically loaded ejecting heart.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966306      PMCID: PMC1664989          DOI: 10.1113/jphysiol.2004.061176

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  25 in total

1.  Myofilament properties comprise the rate-limiting step for cardiac relaxation at body temperature in the rat.

Authors:  Paul M L Janssen; Linda B Stull; Eduardo Marbán
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

2.  Power output is increased after phosphorylation of myofibrillar proteins in rat skinned cardiac myocytes.

Authors:  T J Herron; F S Korte; K S McDonald
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

3.  Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation.

Authors:  Beata M Wolska; Grace M Arteaga; James R Peña; Grzegorz Nowak; Ronald M Phillips; Shalini Sahai; Pieter P de Tombe; Anne F Martin; Evangelia G Kranias; R John Solaro
Journal:  Circ Res       Date:  2002-05-03       Impact factor: 17.367

4.  Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle.

Authors:  J C Kentish; D T McCloskey; J Layland; S Palmer; J M Leiden; A F Martin; R J Solaro
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

5.  Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation.

Authors:  L Li; J Desantiago; G Chu; E G Kranias; D M Bers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-03       Impact factor: 4.733

6.  Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes.

Authors:  Joanne Layland; Jian-Mei Li; Ajay M Shah
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

7.  Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice.

Authors:  YeQing Pi; Kara R Kemnitz; Dahua Zhang; Evangelia G Kranias; Jeffery W Walker
Journal:  Circ Res       Date:  2002-04-05       Impact factor: 17.367

8.  Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.

Authors:  Daniel E Michele; Carlen A Gomez; Katie E Hong; Margaret V Westfall; Joseph M Metzger
Journal:  Circ Res       Date:  2002-08-09       Impact factor: 17.367

9.  Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants.

Authors:  Margaret V Westfall; Andrea R Borton; Faris P Albayya; Joseph M Metzger
Journal:  Circ Res       Date:  2002-09-20       Impact factor: 17.367

10.  Continuous stroke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter.

Authors:  J Baan; T T Jong; P L Kerkhof; R J Moene; A D van Dijk; E T van der Velde; J Koops
Journal:  Cardiovasc Res       Date:  1981-06       Impact factor: 10.787

View more
  27 in total

1.  Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics.

Authors:  Carl W Tong; Robert D Gaffin; David C Zawieja; Mariappan Muthuchamy
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

2.  Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C.

Authors:  Jonathan P Davis; Catalina Norman; Tomoyoshi Kobayashi; R John Solaro; Darl R Swartz; Svetlana B Tikunova
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

Review 3.  The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation.

Authors:  R John Solaro; Paul Rosevear; Tomoyoshi Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

4.  Sarcomere length dependence of power output is increased after PKA treatment in rat cardiac myocytes.

Authors:  Laurin M Hanft; Kerry S McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-27       Impact factor: 4.733

Review 5.  The exercising heart at altitude.

Authors:  José A L Calbet; Paul Robach; Carsten Lundby
Journal:  Cell Mol Life Sci       Date:  2009-10-07       Impact factor: 9.261

6.  Alpha1 catalytic subunit of AMPK modulates contractile function of cardiomyocytes through phosphorylation of troponin I.

Authors:  Si Chen; Ping Zhu; Hui-Ming Guo; Raquel Sancho Solis; Yanqing Wang; Yina Ma; Jinli Wang; Junjie Gao; Ji-Mei Chen; Ying Ge; Jian Zhuang; Ji Li
Journal:  Life Sci       Date:  2014-01-19       Impact factor: 5.037

7.  Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice.

Authors:  Kirsten Keller; Martina Maass; Sara Dizayee; Veronika Leiss; Suvi Annala; Jessica Köth; Wiebke K Seemann; Jochen Müller-Ehmsen; Klaus Mohr; Bernd Nürnberg; Stefan Engelhardt; Stefan Herzig; Lutz Birnbaumer; Jan Matthes
Journal:  Cardiovasc Res       Date:  2015-10-13       Impact factor: 10.787

8.  Role of the acidic N' region of cardiac troponin I in regulating myocardial function.

Authors:  Sakthivel Sadayappan; Natosha Finley; Jack W Howarth; Hanna Osinska; Raisa Klevitsky; John N Lorenz; Paul R Rosevear; Jeffrey Robbins
Journal:  FASEB J       Date:  2007-11-05       Impact factor: 5.191

9.  p38α regulates SERCA2a function.

Authors:  Leena Kaikkonen; Johanna Magga; Veli-Pekka Ronkainen; Elina Koivisto; Ábel Perjes; J Kurt Chuprun; Leif Erik Vinge; Teemu Kilpiö; Jani Aro; Johanna Ulvila; Tarja Alakoski; James A Bibb; Istvan Szokodi; Walter J Koch; Heikki Ruskoaho; Risto Kerkelä
Journal:  J Mol Cell Cardiol       Date:  2013-12-17       Impact factor: 5.000

10.  Protein phosphatase 2A contributes to the cardiac dysfunction induced by endotoxemia.

Authors:  Melanie Marshall; Narayana Anilkumar; Joanne Layland; Simon J Walker; Jonathan C Kentish; Ajay M Shah; Alison C Cave
Journal:  Cardiovasc Res       Date:  2009-02-06       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.